Cognitive stimulation therapy: training, maintenance and implementation in clinical trials.

Area of Science:

• Neuroscience
• Gerontology
• Psychology

Background:

• Alzheimer's disease (AD) affects over 17.5 million people globally, with limited pharmacological treatments offering modest symptomatic relief.
• Current AD treatments primarily focus on managing neuropsychological symptoms, highlighting the need for effective non-pharmacological interventions.

Approach:

• Review of randomized controlled trials (RCTs) evaluating non-pharmacological approaches for AD.
• Focus on Cognitive Stimulation Therapy (CST) as a promising intervention.
• Analysis of evidence supporting CST's benefits for cognition and well-being.

Key Points:

• Cognitive Stimulation Therapy (CST) demonstrates significant benefits for cognitive function and overall well-being in individuals with dementia, including Alzheimer's disease.
• Strong evidence base from RCTs supports the integration of CST into clinical practice for AD management.
• Key areas for future research include long-term efficacy, personalized CST, and combination therapy with pharmacological treatments.

Conclusions:

• Cognitive Stimulation Therapy (CST) is a well-supported non-pharmacological intervention for Alzheimer's disease (AD).
• Clinical implementation of CST is recommended based on current evidence.
• Ongoing research aims to optimize CST protocols and explore its adjunctive benefits.